189 A clear increase in TILs and modest tumor growth inhibition by pembrolizumab in prostate cancer tumors growing in bone of CD34+ engrafted NOG mice

• Suominen Suominen,
• Justyna Zdrojewska,
• Jenni Mäki-Jouppila,
• Philip Dube,
• Ivan Gladwyn-Ng,
• Paul Volden,
• Jukka Rissanen,
• Mari Suominen

Affiliations

Suominen Suominen

1Pharmatest Services, Turku, Finland

Justyna Zdrojewska

1Pharmatest Services, Turku, Finland

Jenni Mäki-Jouppila

1Pharmatest Services, Turku, Finland

Philip Dube

2Taconic Biosciences, Rensselaer, NY, USA

Ivan Gladwyn-Ng

2Taconic Biosciences, Rensselaer, NY, USA

Paul Volden

2Taconic Biosciences, Rensselaer, NY, USA

Jukka Rissanen

1Pharmatest Services, Turku, Finland

Mari Suominen

1Pharmatest Services, Turku, Finland